Early initiation of disease-modifying therapy can impede or prevent diffuse myocardial fibrosis in sickle cell anemia.

ABSTRACT:

SUBMITTER: Niss O 

PROVIDER: S-EPMC9479038 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature